genetic testing
MRC Holland Gets CE-IVDR Certification for Spinal Muscular Atrophy Tests
The company has received certification under Europe's In Vitro Diagnostic Regulation for a number of tests recently.
New York Doctor Found Guilty in $24M Medicare Fraud Scheme Involving Cancer Tests
The doctor was found to have, among other things, ordered genetic cancer tests for patients he never saw.
The clinical genetic testing company's Q4 revenues jumped 64 percent year over year to $95.6 million, driven by its strong exome and whole-genome testing business.
TD Cowen Reinstates Buy Rating for Tempus AI, Raises Price Target to $74
The bank had suspended its rating and price target for Tempus during its $600 million acquisition of Ambry Genetics due to TD Securities' involvement in the deal.
Top Five Articles on 360Dx Last Week: Delayed Non-Coverage Decisions for Some Genetic Tests; More
Last week, readers were most interested in a story about two Medicare administrative contractors delaying the implementation of a policy not to cover certain genetic tests.